Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Emerg (Tehran) ; 5(1): e67, 2017.
Article in English | MEDLINE | ID: mdl-28894782

ABSTRACT

Methotrexate has been used widely in dermatology, oncology and rheumatology fields. However, methotrexate-induced mucocutaneous lesions may occur in rare cases. In this case presentation, we report two cases of accidental poisoning with methotrexate. They had accidentally used methotrexate instead of digoxin. This case report emphasizes that early diagnosis and appropriate management is critical in order to improve outcome.

2.
Urol J ; 14(2): 3040-3042, 2017 Mar 16.
Article in English | MEDLINE | ID: mdl-28299767

ABSTRACT

Isolated renal hydatid cyst is a rare entity accounting for only 2-4% of cases. A 60-year-old male presented to our clinic complaining of pain in right flank. He had a history of eating raw sheep liver. Imaging revealed an expansive cystic mass measuring approximately300×180 mm in the right side of abdomen. The patient was treated by open surgery in combination with perioperative chemotherapy with albendazol. In this case, we reported an unusual presentation of hydatid cyst disease. Physicians should be aware of its clinical presentations and complications.


Subject(s)
Echinococcosis/complications , Echinococcosis/diagnostic imaging , Kidney Diseases/diagnostic imaging , Kidney Diseases/parasitology , Echinococcosis/therapy , Flank Pain/parasitology , Humans , Kidney Diseases/therapy , Male , Middle Aged , Tomography, X-Ray Computed , Ultrasonography
3.
Int J Biochem Cell Biol ; 55: 318-28, 2014 Oct.
Article in English | MEDLINE | ID: mdl-25150833

ABSTRACT

Stem cells (SCs) have self-renew ability and give rise to committed progenitors of a single or multiple lineages. Elucidating the genetic circuits that govern SCs to self-renew and to differentiate is essential to understand the roles of SCs and promise of these cells in regenerative medicine. MicroRNAs are widespread agents playing critical roles in regulatory networks of transcriptional expression and have been strongly linked with SCs for simultaneous maintenance of pluripotency properties such as self-renewal. This review aims to provide state-of-the-art presentations on microRNA-dependent molecular mechanisms contribute to the maintenance of pluripotency. Understanding the microRNA signature interactions, in conjunction with cell signaling, is critical for development of improved strategies to reprogram differentiated cells or direct differentiation of pluripotent cells.


Subject(s)
Cell Dedifferentiation/genetics , Cell Differentiation/genetics , Cellular Reprogramming/genetics , MicroRNAs/genetics , Stem Cells/metabolism , Embryonic Stem Cells/metabolism , Gene Expression Profiling , Humans , Models, Genetic , Pluripotent Stem Cells/metabolism
4.
Int J Cardiol ; 173(1): 12-9, 2014 Apr 15.
Article in English | MEDLINE | ID: mdl-24612559

ABSTRACT

Stem cells hold a great promise for regenerative medicine, especially for replacing cells in infarcted organ that hardly have any intrinsic renewal capacity, including heart and brain. Signaling pathways that regulate pluripotency or lineage-specific gene and protein expression have been the major focus of stem cell research. Between them, there are some well known signaling pathways such as GF/GFR systems, SDF-1α/CXC4 ligand receptor interaction and PI3K/Akt signaling, and cytokines may regulate cell fate decisions, and can be utilized to positively influence cell therapy outcomes or accentuate synergistic compliance. For example, contributing factors in the progression of heart failure are both the loss of cardiomyocytes after myocardial infarction, and the absence of an adequate endogenous repair signaling. Combining cell engraftment with therapeutic signaling factor delivery is more exciting in terms of host progenitor/donor stem cell survival and proliferation. Thus stem cell-based therapy, besides triggering signaling pathways through GF/GFR systems can become a realistic option in regenerative processes for replacing lost cells and reconstituting the damaged organ, as before.


Subject(s)
Heart Failure/therapy , Intercellular Signaling Peptides and Proteins/administration & dosage , Regenerative Medicine/trends , Stem Cell Transplantation/trends , Animals , Cell Differentiation/drug effects , Cell Differentiation/physiology , Cell Proliferation/drug effects , Cell Proliferation/physiology , Chemokines/metabolism , Combined Modality Therapy/methods , Combined Modality Therapy/trends , Heart Failure/drug therapy , Heart Failure/metabolism , Humans , Intercellular Signaling Peptides and Proteins/metabolism , Regenerative Medicine/methods , Stem Cell Transplantation/methods , Stem Cells/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...